Related Experiment Videos
[Prognostic factors in early inflammatory arthritis]
1Fédération de rhumatologie, hôpital Lapeyronie, Montpellier, France.
La Revue De Medecine Interne
|January 1, 1996
Summary
Identifying early indicators for rheumatoid arthritis (RA) and spondylarthropathies is crucial. Key prognostic markers include ESR, CRP, rheumatoid factor, and genetic factors like HLA-DRB1 alleles, aiding in personalized treatment strategies.
Area of Science:
- Rheumatology
- Immunology
- Molecular Biology
Context:
- Rheumatoid arthritis (RA) and spondylarthropathies are common chronic inflammatory arthritides.
- RA heterogeneity impacts disease course and treatment response.
- Lack of universally accepted prognostic factors complicates patient management.
Purpose:
- To identify and validate prognostic markers for rheumatoid arthritis and spondylarthropathies.
- To enable clinicians to tailor management strategies based on disease potential.
- To explore genetic and molecular markers for predicting disease severity and progression.
Summary:
- Early indicators for RA prognosis include ESR, CRP, and rheumatoid factor.
- Genetic markers like HLA-DRB1 alleles may correlate with RA severity.
- Spondylarthropathies prognosis factors include early onset, hip arthritis, and inflammatory markers.
Impact:
- Establishes potential biomarkers for early RA and spondylarthropathies detection and severity assessment.
- Facilitates personalized medicine by identifying patient subgroups.
- Highlights the need for further research into genetic and molecular prognostic factors.